Gene delivery strategies for cartilage tissue engineering

Advanced Drug Delivery Reviews

Volumn 58, Issue 4, 2006, Pages 592-603

  Saraf, Anita ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

Cartilage tissue engineering; Chondrocytes; Gene delivery; Gene delivery vectors; Gene Therapy; Genes; MSCs; Synovial cells

Indexed keywords

BIOLOGICAL ORGANS; BIOMEDICAL ENGINEERING; CELLS; CONTROLLED DRUG DELIVERY; DISEASES; TISSUE;

CARTILAGE TISSUE ENGINEERING; CHONDROCYTES]; GENE DELIVERY; GENE DELIVERY VECTORS; MSCS; SYNOVIAL CELLS;

GENES;

ALGINIC ACID; ANTIINFLAMMATORY AGENT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOSOME; OSTEOGENIC PROTEIN 1; POLYGLYCOLIC ACID; RETROVIRUS VECTOR; SMAD PROTEIN; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VIRUS VECTOR;

ARTHROPATHY; BIOMECHANICS; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL BASED GENE THERAPY; CHONDROGENESIS; CHONDROPATHY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; REGENERATION; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; SYNOVIOCYTE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CARTILAGE; CELL CULTURE TECHNIQUES; CHONDROCYTES; GENE TRANSFER TECHNIQUES; HUMANS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 33745246342     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.03.005     Document Type: Review

References (48)

1. Racial/ethnic differences in the prevalence and impact of doctor-diagnosed arthritis - United States, 2002. MMWR Morb. Mort. Wkly. Rep. 54 (2005) 119-123
2. Madry H., Kaul G., Cucchiarini M., Stein U., Zurakowski D., Remberger K., Menger M.D., Kohn D., and Trippel S.B. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther.. 12 (2005) 1171-1179
3. Laurencin C.T., Ambrosio A.M., Borden M.D., and Cooper Jr. J.A. Tissue engineering: orthopedic applications. Annu. Rev. Biomed. Eng. 1 (1999) 19-46
4. Mason J.M., Breitbart A.S., Barcia M., Porti D., Pergolizzi R.G., and Grande D.A. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin. Orthop. Relat. Res. (2000) S171-S178
5. Kofron M.D., and Laurencin C.T. Orthopaedic applications of Gene Therapy. Curr. Gene Ther. 5 (2005) 37-61
6. Visna P., Pasa L., Cizmar I., Hart R., and Hoch J. Treatment of deep cartilage defects of the knee using autologous chondrograft transplantation and by abrasive techniques - a randomized controlled study. Acta Chir. Belg. 104 (2004) 709-714
7. Bachmann G., Basad E., Lommel D., and Steinmeyer J. [MRI in the follow-up of matrix-supported autologous chondrocyte transplantation (MACI) and microfracture]. Radiologe 44 (2004) 773-782
8. Kolettas E., Muir H.I., Barrett J.C., and Hardingham T.E. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor. Rheumatology (Oxford) 40 (2001) 1146-1156
9. Hardingham T., Tew S., and Murdoch A. Tissue engineering: chondrocytes and cartilage. Arthritis Res. 4 Suppl 3 (2002) S63-S68
10. Young A.A., Smith M.M., Smith S.M., Cake M.A., Ghosh P., Read R.A., Melrose J., Sonnabend D.H., Roughley P.J., and Little C.B. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res. Ther. 7 (2005) R852-R861
11. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., and Goldberg V.M. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Jt. Surg., Am. 76 (1994) 579-592
12. Solchaga L.A., Goldberg V.M., and Caplan A.I. Cartilage regeneration using principles of tissue engineering. Clin. Orthop. Relat. Res. (2001) S161-S170
13. Jorgensen C., Gordeladze J., and Noel D. Tissue engineering through autologous mesenchymal stem cells. Curr. Opin. Biotechnol. 15 (2004) 406-410
14. Saxer R.A., Bent S.J., Brower-Toland B.D., Mi Z., Robbins P.D., Evans C.H., and Nixon A.J. Gene mediated insulin-like growth factor-I delivery to the synovium. J. Orthop. Res. 19 (2001) 759-767
15. Nixon A.J., Brower-Toland B.D., Bent S.J., Saxer R.A., Wilke M.J., Robbins P.D., and Evans C.H. Insulinlike growth factor-I Gene Therapy applications for cartilage repair. Clin. Orthop. Relat. Res. (2000) S201-S213
16. Sellers R.S., Peluso D., and Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J. Bone Jt. Surg., Am. 79 (1997) 1452-1463
17. Gelse K., von der Mark K., Aigner T., Park J., and Schneider H. Articular cartilage repair by Gene Therapy using growth factor-producing mesenchymal cells. Arthritis Rheum. 48 (2003) 430-441
18. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noel D., and Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102 (2003) 3837-3844
19. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., and Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57 (2003) 11-20
20. Evans C.H., Ghivizzani S.C., Kang R., Muzzonigro T., Wasko M.C., Herndon J.H., and Robbins P.D. Gene Therapy for rheumatic diseases. Arthritis Rheum. 42 (1999) 1-16
21. Trippel S.B., Ghivizzani S.C., and Nixon A.J. Gene-based approaches for the repair of articular cartilage. Gene Ther. 11 (2004) 351-359
22. Gouze E., Pawliuk R., Pilapil C., Gouze J.N., Fleet C., Palmer G.D., Evans C.H., Leboulch P., and Ghivizzani S.C. In vivo gene delivery to synovium by lentiviral vectors. Molec. Ther. 5 (2002) 397-404
23. Evans C.H., Ghivizzani S.C., Herndon J.H., Wasko M.C., Reinecke J., Wehling P., and Robbins P.D. Clinical trials in the Gene Therapy of arthritis. Clin. Orthop. Relat. Res. (2000) S300-S307
24. Makarov S.S., Olsen J.C., Johnston W.N., Anderle S.K., Brown R.R., Baldwin Jr. A.S., Haskill J.S., and Schwab J.H. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 402-406
25. Bakker A.C., van de Loo F.A., van Beuningen H.M., Sime P., van Lent P.L., van der Kraan P.M., Richards C.D., and van den Berg W.B. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthr. Cartil. 9 (2001) 128-136
26. Mi Z., Ghivizzani S.C., Lechman E., Glorioso J.C., Evans C.H., and Robbins P.D. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res. Ther. 5 (2003) R132-R139
27. Tuli R., Tuli S., Nandi S., Huang X., Manner P.A., Hozack W.J., Danielson K.G., Hall D.J., and Tuan R.S. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J. Biol. Chem. 278 (2003) 41227-41236
28. Shuler F.D., Georgescu H.I., Niyibizi C., Studer R.K., Mi Z., Johnstone B., Robbins R.D., and Evans C.H. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J. Orthop. Res. 18 (2000) 585-592
29. Alvarez J., Sohn P., Zeng X., Doetschman T., Robbins D.J., and Serra R. TGFbeta2 mediates the effects of hedgehog on hypertrophic differentiation and PTHrP expression. Development 129 (2002) 1913-1924
30. Pepper M.S., Montesano R., Vassalli J.D., and Orci L. Chondrocytes inhibit endothelial sprout formation in vitro: evidence for involvement of a transforming growth factor-beta. J. Cell. Physiol. 146 (1991) 170-179
31. Lee J.Y., Hall R., Pelinkovic D., Cassinelli E., Usas A., Gilbertson L., Huard J., and Kang J. New use of a three-dimensional pellet culture system for human intervertebral disc cells: initial characterization and potential use for tissue engineering. Spine 26 (2001) 2316-2322
32. Grande D.A., Mason J., Light E., and Dines D. Stem cells as platforms for delivery of genes to enhance cartilage repair. J. Bone Jt. Surg., Am. 85-A Suppl 2 (2003) 111-116
33. Smith P., Shuler F.D., Georgescu H.I., Ghivizzani S.C., Johnstone B., Niyibizi C., Robbins P.D., and Evans C.H. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum. 43 (2000) 1156-1164
34. Semba I., Nonaka K., Takahashi I., Takahashi K., Dashner R., Shum L., Nuckolls G.H., and Slavkin H.C. Positionally-dependent chondrogenesis induced by BMP4 is co-regulated by Sox9 and Msx2. Dev. Dyn. 217 (2000) 401-414
35. Ikeda T., Kamekura S., Mabuchi A., Kou I., Seki S., Takato T., Nakamura K., Kawaguchi H., Ikegawa S., and Chung U.I. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 50 (2004) 3561-3573
36. Hoffmann A., Czichos S., Kaps C., Bachner D., Mayer H., Kurkalli B.G., Zilberman Y., Turgeman G., Pelled G., Gross G., and Gazit D. The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J. Cell Sci. 115 (2002) 769-781
37. Apparailly F., Verwaerde C., Jacquet C., Auriault C., Sany J., and Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160 (1998) 5213-5220
38. Bessis N., Honiger J., Damotte D., Minty A., Fournier C., Fradelizi D., and Boissier M. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA). Clin. Exp. Immunol. 117 (1999) 376-382
39. Bakker A.C., Joosten L.A., Arntz O.J., Helsen M.M., Bendele A.M., van de Loo F.A., and van den Berg W.B. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum. 40 (1997) 893-900
40. Verma I.M., and Somia N. Gene Therapy - promises, problems and prospects. Nature 389 (1997) 239-242
41. Lubberts E., Joosten L.A., Chabaud M., van Den Bersselaar L., Oppers B., Coenen-De Roo C.J., Richards C.D., Miossec P., and van Den Berg W.B. IL-4 Gene Therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J. Clin. Invest. 105 (2000) 1697-1710
42. Gelse K., Jiang Q.J., Aigner T., Ritter T., Wagner K., Poschl E., von der Mark K., and Schneider H. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum. 44 (2001) 1943-1953
43. Goomer R.S., Maris T.M., Gelberman R., Boyer M., Silva M., and Amiel D. Nonviral in vivo Gene Therapy for tissue engineering of articular cartilage and tendon repair. Clin. Orthop. Relat. Res. (2000) S189-S200
44. Baragi V.M., Renkiewicz R.R., Qiu L., Brammer D., Riley J.M., Sigler R.E., Frenkel S.R., Amin A., Abramson S.B., and Roessler B.J. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthr. Cartil. 5 (1997) 275-282
45. Adachi N., Sato K., Usas A., Fu F.H., Ochi M., Han C.W., Niyibizi C., and Huard J. Muscle derived, cell based ex vivo Gene Therapy for treatment of full thickness articular cartilage defects. J. Rheumatol. 29 (2002) 1920-1930
46. Ho Y.C., Chen H.C., Wang K.C., and Hu Y.C. Highly efficient baculovirus-mediated gene transfer into rat chondrocytes. Biotechnol. Bioeng. 88 (2004) 643-651
47. Dinser R., Kreppel F., Zaucke F., Blank C., Paulsson M., Kochanek S., and Maurer P. Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochem. Cell Biol. 116 (2001) 69-77
48. Doherty P.J., Zhang H., Tremblay L., Manolopoulos V., and Marshall K.W. Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. Osteoarthr. Cartil. 6 (1998) 153-159